JP2020521474A - 塞がれた気流要素を有する吸入器物品 - Google Patents
塞がれた気流要素を有する吸入器物品 Download PDFInfo
- Publication number
- JP2020521474A JP2020521474A JP2019565528A JP2019565528A JP2020521474A JP 2020521474 A JP2020521474 A JP 2020521474A JP 2019565528 A JP2019565528 A JP 2019565528A JP 2019565528 A JP2019565528 A JP 2019565528A JP 2020521474 A JP2020521474 A JP 2020521474A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- tube
- nicotine
- inner tube
- inhaler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 167
- 229960002715 nicotine Drugs 0.000 claims description 161
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 161
- 239000002775 capsule Substances 0.000 claims description 128
- 239000002245 particle Substances 0.000 claims description 128
- 239000000843 powder Substances 0.000 claims description 116
- 239000000796 flavoring agent Substances 0.000 claims description 111
- 235000019634 flavors Nutrition 0.000 claims description 81
- 239000011148 porous material Substances 0.000 claims description 32
- 230000000903 blocking effect Effects 0.000 claims description 26
- 230000001939 inductive effect Effects 0.000 claims description 23
- 238000007789 sealing Methods 0.000 claims description 18
- 238000011144 upstream manufacturing Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 8
- 229920002301 cellulose acetate Polymers 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 230000000149 penetrating effect Effects 0.000 claims 1
- 230000004888 barrier function Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 description 33
- 235000013355 food flavoring agent Nutrition 0.000 description 30
- 150000001875 compounds Chemical class 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 11
- 230000000391 smoking effect Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 7
- 235000019504 cigarettes Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000000779 smoke Substances 0.000 description 5
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 5
- 239000004395 L-leucine Substances 0.000 description 4
- 235000019454 L-leucine Nutrition 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 3
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940005605 valeric acid Drugs 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- JZBCTZLGKSYRSF-UHFFFAOYSA-N 2-Ethyl-3,5-dimethylpyrazine Chemical compound CCC1=NC=C(C)N=C1C JZBCTZLGKSYRSF-UHFFFAOYSA-N 0.000 description 2
- MMOPGICOOYBFJU-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.CN1CCCC1C1=CC=CN=C1 MMOPGICOOYBFJU-UHFFFAOYSA-N 0.000 description 2
- FFYVQVZXWDGRAY-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrate Chemical compound O.CN1CCCC1C1=CC=CN=C1 FFYVQVZXWDGRAY-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LDMPZNTVIGIREC-ZGPNLCEMSA-N nicotine bitartrate Chemical compound O.O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 LDMPZNTVIGIREC-ZGPNLCEMSA-N 0.000 description 2
- 229940069688 nicotine bitartrate Drugs 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GKTOAHZEMRRUKF-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)[C@@H](N)CCC(O)=O.CN1CCCC1C1=CC=CN=C1 GKTOAHZEMRRUKF-HVDRVSQOSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- SKZDZXPBBYUFBY-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCCC1C1=CC=CN=C1 SKZDZXPBBYUFBY-WLHGVMLRSA-N 0.000 description 1
- 239000001363 2-ethyl-3,5-dimethylpyrazine Substances 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- VWTHFJXLFGINSW-PPHPATTJSA-N 2-hydroxypropanoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CC(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 VWTHFJXLFGINSW-PPHPATTJSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- YKVWPZJHENXDAJ-VOTSOKGWSA-N Megastigmatrienone Chemical compound CC1=CC(=O)CC(C)(C)C1\C=C\C=C YKVWPZJHENXDAJ-VOTSOKGWSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000021063 Respiratory fume inhalation disease Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- PQDRXUSSKFWCFA-CFNZNRNTSA-N solanone Chemical compound CC(=O)CC[C@@H](C(C)C)\C=C\C(C)=C PQDRXUSSKFWCFA-CFNZNRNTSA-N 0.000 description 1
- PQDRXUSSKFWCFA-UHFFFAOYSA-N solanone Natural products CC(=O)CCC(C(C)C)C=CC(C)=C PQDRXUSSKFWCFA-UHFFFAOYSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/05—Devices without heating means
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/20—Devices using solid inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/30—Devices using two or more structurally separated inhalable precursors, e.g. using two liquid precursors in two cartridges
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
- A24F40/48—Fluid transfer means, e.g. pumps
- A24F40/485—Valves; Apertures
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/20—Devices without heating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
- A61M15/0036—Piercing means hollow piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Abstract
Description
Claims (13)
- 吸入器物品であって、
長軸方向軸に沿ってマウスピース端から消耗品受け側端に延びるホルダー本体を画定する管状ハウジングであって、前記ホルダー本体が、
前記長軸方向軸に沿って前記管状ハウジング内で管の取り込み側端から管の排出側端に延びる内側管であって、前記管取り込み口端が前記消耗品受け側端の近傍にあり、前記内側管が、前記内側管の壁を通って延びる二つ以上の気流開口部を備える気流内腔を画定し、空気遮断特徴が気流内腔内に、かつ二つの気流開口部間に位置付けられている、内側管と、
前記管の排出側端または前記管の取り込み側端の近傍にある前記内側管上に配置された振動誘発要素であって、前記振動誘発要素が前記内側管の前記壁を貫通し、先細りしたまたは角度の付いた下流開口部端を有する、振動誘発要素とを備える、吸入器物品。 - 前記空気遮断特徴が前記管の取り込み側端から下流の気流内腔内に配置されていて、少なくとも一つの気流開口部が管の空気出口を画定し、前記遮断特徴と前記管の取り込み側端との間にあり、少なくとも一つの気流開口部が管の空気吸込み口を画定し、前記遮断特徴と前記管の排出側端との間にあり、前記管排気口が前記マウスピース端と気流連通している、請求項1に記載の吸入器物品。
- 少なくとも3つの気流開口部が、前記空気遮断特徴の上流かつそれに隣接して位置し、少なくとも3つの気流開口部が、前記空気遮断特徴の下流かつそれに隣接して位置する、請求項1〜2のいずれか一項に記載の吸入器物品。
- 前記管状ハウジング内に位置付けられていて、前記マウスピース端を前記消耗品受け側端から分離し、前記内側管が前記空気密封要素を通って延びる、空気密封要素をさらに備える、請求項1〜3のいずれか一項に記載の吸入器物品。
- 前記管状ハウジングおよび前記内側管が同軸である、請求項1〜4のいずれか一項に記載の吸入器物品。
- 前記内側管上に配置されたカプセルをさらに備え、前記内側管が前記カプセルの対向する側面を通って延び、前記カプセルがニコチンまたはその薬学的に許容可能な塩を含む、請求項1〜5のいずれか一項に記載の吸入器物品。
- 前記空気遮断特徴および気流開口部が前期カプセル内に位置付けられていて、前記管の取り込み側端が前記カプセルから遠位に延び、前記管の空気出口が前記カプセルから近位に延びる、請求項8に記載の吸入器物品。
- 吸入器システムであって、
請求項1〜7のいずれか一項に記載の吸入器物品と、
前記ホルダー本体の前記消耗品受け側端に受けられるように構成されたニコチン粉末消費者物品であって、前記ニコチン粉末消費者物品が、
近位端と遠位端の間に延びる細長い消耗品本体と、
前記細長い消耗品本体内に固定されたカプセルであって、前記カプセルがニコチンまたはその薬学的に許容可能な塩を含む粒子を含有する、カプセルと、
前記カプセルが前記内側管上に配置されていて、前記内側管が前記カプセルの向かい合った側を通って延び、前記管の取り込み側端が、ニコチン粉末消費者物品が前記ホルダー本体の前記消耗品受け側端内に受けられている時に、前記カプセルから遠位に延びる、吸入器システム。 - 多孔性材料の第一のプラグが前記細長い消耗体の前記近位端内に配置されていて、多孔性材料の第二のプラグが前記細長い消耗品本体の前記遠位端内に配置されている、請求項8に記載の吸入器システム。
- 前記多孔性材料の前記第一のプラグがセルロースアセテートトウを含み、前記多孔性材料多孔性材料の前記第二のプラグがセルロースアセテートトウを含む、請求項9に記載の吸入器システム。
- 前記多孔性材料の第一のプラグおよび前記多孔性材料の第二のプラグが、前記カプセルを前記細長い消耗品本体内に固定する、請求項9または10に記載の吸入器システム。
- 前記多孔性材料の第二のプラグが風味送達要素を含む、請求項9〜11のいずれか一項に記載の吸入器システム。
- 前記管の取り込み側端が前記多孔性材料の第二のプラグ内に延びる、請求項9〜12のいずれか一項に記載の吸入器システム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17173762 | 2017-05-31 | ||
EP17173762.0 | 2017-05-31 | ||
PCT/IB2018/053619 WO2018220475A1 (en) | 2017-05-31 | 2018-05-22 | Inhaler article with occluded airflow element |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020521474A true JP2020521474A (ja) | 2020-07-27 |
JP7183191B2 JP7183191B2 (ja) | 2022-12-05 |
Family
ID=59021274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019565528A Active JP7183191B2 (ja) | 2017-05-31 | 2018-05-22 | 塞がれた気流要素を有する吸入器物品 |
Country Status (13)
Country | Link |
---|---|
US (1) | US11452825B2 (ja) |
EP (1) | EP3630242B1 (ja) |
JP (1) | JP7183191B2 (ja) |
KR (1) | KR102622538B1 (ja) |
CN (1) | CN110603067B (ja) |
BR (1) | BR112019023202A2 (ja) |
IL (1) | IL270586B2 (ja) |
MX (1) | MX2019014016A (ja) |
MY (1) | MY195310A (ja) |
PH (1) | PH12019502180A1 (ja) |
RU (1) | RU2761750C2 (ja) |
UA (1) | UA126152C2 (ja) |
WO (1) | WO2018220475A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019022109A8 (pt) | 2017-03-17 | 2023-10-24 | Karkairan Ryan | Cápsula de vaporizador de fundo fechado, vaporizador e sistema para vaporização de materiais vaporizáveis |
PL4057845T3 (pl) * | 2019-11-14 | 2024-03-25 | Philip Morris Products S.A. | Ulepszony preparat w postaci suchego proszku o aromacie tytoniowym |
WO2024053914A1 (en) * | 2022-09-06 | 2024-03-14 | Kt & G Corporation | Inhaler |
WO2024053883A1 (en) * | 2022-09-06 | 2024-03-14 | Kt & G Corporation | Inhaler with photoplethysmography sensor |
WO2024053942A1 (en) * | 2022-09-06 | 2024-03-14 | Kt & G Corporation | Inhaler providing vibration for powder inhalation |
EP4360475A1 (en) * | 2022-10-25 | 2024-05-01 | JT International SA | Device for inhaling dry particles of nicotine-based substance |
WO2024091005A1 (ko) * | 2022-10-27 | 2024-05-02 | 주식회사 케이티앤지 | 기침 억제제를 함유한 건조 분말 흡입기용 스틱 및 이를 포함한 건조 분말 흡입기 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3888253A (en) * | 1972-08-04 | 1975-06-10 | Beecham Group Ltd | Device for administration of medicines |
JPS5615759A (en) * | 1979-04-27 | 1981-02-16 | Sigma Tau Ind Farmaceuti | Sucking tool for powdered medicine |
JPH09262295A (ja) * | 1996-03-29 | 1997-10-07 | Maeda Sangyo Kk | 粉末状薬剤吸入装置 |
JP2001187143A (ja) * | 1993-07-30 | 2001-07-10 | Ernst Hoerlin | 粉末吸入器 |
EP2022526A1 (en) * | 2007-08-01 | 2009-02-11 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhaler |
CN101489612A (zh) * | 2006-04-05 | 2009-07-22 | 微量技术有限公司 | 可变剂量吸入装置 |
US20110220106A1 (en) * | 2006-03-10 | 2011-09-15 | Dose One, Llc | Medication inhaler for dispensing multiple capsules |
US20140166004A1 (en) * | 2012-12-19 | 2014-06-19 | Carefusion 303, Inc. | Nebulizer with integrated breathing incentive |
JP2015513427A (ja) * | 2012-03-09 | 2015-05-14 | ベクチュラ・ゲーエムベーハー | 吸入用装置及び吸入用装置のための混合流路 |
JP2015521526A (ja) * | 2012-06-25 | 2015-07-30 | レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. | 粉末分散デバイスおよび方法 |
WO2015193498A1 (en) * | 2014-06-20 | 2015-12-23 | Philip Morris Products S.A. | Nicotine powder delivery system with airflow management means |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0470154B1 (en) | 1989-04-28 | 1996-06-05 | Riker Laboratories, Inc. | Dry powder inhalation device |
DE19502725B4 (de) | 1995-01-28 | 2004-03-04 | Ing. Erich Pfeiffer Gmbh & Co Kg | Austragvorrichtung für Medien |
CA2146954C (en) | 1995-04-12 | 2008-06-17 | Arthur Slutsky | Breath activated nicotine inhalers |
GB9814368D0 (en) * | 1998-07-02 | 1998-09-02 | Reckitt & Colmann Prod Ltd | Inhalation of aerosol actives |
US7464706B2 (en) * | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
JP2009532189A (ja) * | 2006-04-05 | 2009-09-10 | マイクロドース セラピューテクス,インコーポレイテッド | 可変量の薬剤を供給する吸入装置 |
BRPI1012702B1 (pt) | 2009-03-17 | 2021-07-06 | Philip Morris Products S.A. | Dispositivo para aplicar nicotina a um paciente, método de aplicação de nicotina em um paciente pela inalação e método de substituição do produto de tabaco |
CN103038141A (zh) | 2010-04-06 | 2013-04-10 | 雷西尔国际有限合作公司 | 用于分配计量体积的纯净或无菌可流动物质的输送*** |
TW201340893A (zh) | 2011-12-20 | 2013-10-16 | British American Tobacco Co | 吸煙物件及其他氣流輸送物件(一) |
JP6397493B2 (ja) | 2013-07-11 | 2018-09-26 | アレックザ ファーマシューティカルズ, インコーポレイテッド | メタ−サリチル酸とのニコチン塩 |
GB2530980A (en) | 2014-09-19 | 2016-04-13 | Kind Consumer Ltd | Simulated cigarette |
EP3519025B1 (en) * | 2016-09-30 | 2022-11-23 | De Motu Cordis Pty Ltd | Delivery device |
-
2018
- 2018-05-22 RU RU2019143705A patent/RU2761750C2/ru active
- 2018-05-22 JP JP2019565528A patent/JP7183191B2/ja active Active
- 2018-05-22 MX MX2019014016A patent/MX2019014016A/es unknown
- 2018-05-22 BR BR112019023202A patent/BR112019023202A2/pt active Search and Examination
- 2018-05-22 MY MYPI2019004424A patent/MY195310A/en unknown
- 2018-05-22 KR KR1020197033929A patent/KR102622538B1/ko active IP Right Grant
- 2018-05-22 US US16/612,543 patent/US11452825B2/en active Active
- 2018-05-22 EP EP18729500.1A patent/EP3630242B1/en active Active
- 2018-05-22 WO PCT/IB2018/053619 patent/WO2018220475A1/en active Application Filing
- 2018-05-22 CN CN201880030194.6A patent/CN110603067B/zh active Active
- 2018-05-22 UA UAA201910199A patent/UA126152C2/uk unknown
-
2019
- 2019-09-23 PH PH12019502180A patent/PH12019502180A1/en unknown
- 2019-11-12 IL IL270586A patent/IL270586B2/en unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3888253A (en) * | 1972-08-04 | 1975-06-10 | Beecham Group Ltd | Device for administration of medicines |
JPS5615759A (en) * | 1979-04-27 | 1981-02-16 | Sigma Tau Ind Farmaceuti | Sucking tool for powdered medicine |
JP2001187143A (ja) * | 1993-07-30 | 2001-07-10 | Ernst Hoerlin | 粉末吸入器 |
JPH09262295A (ja) * | 1996-03-29 | 1997-10-07 | Maeda Sangyo Kk | 粉末状薬剤吸入装置 |
US20110220106A1 (en) * | 2006-03-10 | 2011-09-15 | Dose One, Llc | Medication inhaler for dispensing multiple capsules |
CN101489612A (zh) * | 2006-04-05 | 2009-07-22 | 微量技术有限公司 | 可变剂量吸入装置 |
EP2022526A1 (en) * | 2007-08-01 | 2009-02-11 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhaler |
JP2015513427A (ja) * | 2012-03-09 | 2015-05-14 | ベクチュラ・ゲーエムベーハー | 吸入用装置及び吸入用装置のための混合流路 |
JP2015521526A (ja) * | 2012-06-25 | 2015-07-30 | レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. | 粉末分散デバイスおよび方法 |
US20140166004A1 (en) * | 2012-12-19 | 2014-06-19 | Carefusion 303, Inc. | Nebulizer with integrated breathing incentive |
WO2015193498A1 (en) * | 2014-06-20 | 2015-12-23 | Philip Morris Products S.A. | Nicotine powder delivery system with airflow management means |
Also Published As
Publication number | Publication date |
---|---|
US11452825B2 (en) | 2022-09-27 |
CN110603067A (zh) | 2019-12-20 |
IL270586B1 (en) | 2023-01-01 |
EP3630242B1 (en) | 2021-05-05 |
CN110603067B (zh) | 2022-04-05 |
WO2018220475A1 (en) | 2018-12-06 |
BR112019023202A2 (pt) | 2020-05-19 |
MY195310A (en) | 2023-01-12 |
RU2019143705A (ru) | 2021-06-30 |
UA126152C2 (uk) | 2022-08-25 |
KR102622538B1 (ko) | 2024-01-11 |
JP7183191B2 (ja) | 2022-12-05 |
IL270586B2 (en) | 2023-05-01 |
RU2761750C2 (ru) | 2021-12-13 |
IL270586A (ja) | 2019-12-31 |
RU2019143705A3 (ja) | 2021-07-09 |
KR20200014750A (ko) | 2020-02-11 |
PH12019502180A1 (en) | 2020-06-08 |
EP3630242A1 (en) | 2020-04-08 |
MX2019014016A (es) | 2020-02-17 |
US20200197637A1 (en) | 2020-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210153545A1 (en) | Flavoured nicotine powder inhaler | |
RU2735143C2 (ru) | Система доставки никотинового порошка | |
KR102494208B1 (ko) | 소용돌이 단부 플러그를 갖는 흡입기 | |
JP7183191B2 (ja) | 塞がれた気流要素を有する吸入器物品 | |
JP7356430B2 (ja) | 乾燥粉末吸入器 | |
EP3393565B1 (en) | Nicotine particle capsule | |
KR102545359B1 (ko) | 맞춤 크기의 공동을 갖는 흡입기 | |
CN109219462B (zh) | 尼古丁粒子递送耗材 | |
KR102633996B1 (ko) | 니코틴 분말 소모품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210428 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220623 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220831 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221024 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7183191 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |